CONTACT US   |  (864) 397-5101

DeGen Medical and MRIguidance partner for surgical care technologies

DeGen Medical

DeGen Medical has collaborated with medical imaging software company MRIguidance to transform surgical care by leveraging advanced technologies.

The companies aim to establish new benchmarks in implant selection, surgical planning and postoperative care with the integration of 3D patient-specific implants, PurI-Ti technology and augmented reality with BoneMRI (synthetic CT) software that eliminates exposure to radiation.

Both entities are said to reshape surgical medicine by providing enhanced patient outcomes and enhancing the quality of life for people worldwide.

MRIguidance’s BoneMRI software delivers detailed 3D anatomical reconstructions directly from only one magnetic resonance imaging (MRI) exam.

This is expected to be beneficial for adolescents.

It is said to be the first imaging technique that visualises both bone and soft tissue in a single examination without utilising harmful ionising radiation.

MRIguidance CEO Rik Jacobs said that he is excited to partner with DeGen Medical to introduce the solutions from both companies to the market in the US for optimising surgical workflows driven by innovations.

Patient-centric medical device development company DeGen Medical offers advanced implants and instrumentation solutions.

It is focused on the development of solutions for complex spinal disorders.

Augmented reality patient education boosts surgeon skills in planning and precision, leading to better patient satisfaction, according to the company.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.